Feature Channels:
Stem Cells
Filters:
MedicineScienceChannels:Glycosylation, Stem Cell, Ricin |
Glycosylation is the most abundant protein modification - over half of the proteins in our cells are ‘decorated’ with glycans. These sugar structures alter protein activities in all organisms – from bacteria to human - influencing fundamental processes, like protein folding and transport, cell migration, cell-cell interactions, and immune responses. |
Embargo expired: 20-Sep-2017 1:00 PM EDT
Released: 19-Sep-2017 10:05 AM EDT
Institute of Molecular Biotechnology |
MedicineScienceChannels:All Journal News, Cell Biology, Neuro, Stem Cells, Local - California, Local - LA Metro, Grant Funded News Stem Cells Development Regeneration, Bone morphogenetic protein, sensory interneurons, Neurons, spinal cord development, Spinal Cord Injury, Sci Treatment And Recovery, Paralysis, Sensory Neurons, Neuron development, Neuroscience, Embryonic Stem Cell Research, Central Nervous System Injuries, spinal cord injury research |
A recent study led by Samantha Butler at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA has overturned a common belief about how a certain class of proteins in the spinal cord regulate the formation of nervous system cells—called neurons—during embryonic development. |
Released: 19-Sep-2017 1:05 PM EDT
UCLA Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research |
MedicineChannels:AIDS and HIV, Autoimmune Diseases, Behavioral Science, Biotech, Bone Health, Cell Biology, Chemistry, Children's Health, Infectious Diseases, Men's Health, Mental Health, Military Health, Public Health, Regenerative Medicine, Seniors, Sex and Relationships, Sleep, Stem Cells, Women's Health, Local - Virginia |
Clues on a Successful Vaccine, Tick Saliva, Natural Immune Response, and More in the AIDS and HIV News SourceThe latest research, features, and experts on HIV and AIDS. |
Released: 15-Sep-2017 4:05 PM EDT
Newswise |
MedicineChannels:Cardiovascular Health, Cell Biology, Heart Disease, Grant Funded News, Local - Pennsylvania, Budgets and Funding, Stem Cells Temple, Temple University Hospital, Temple Hospital , Philadelphia, North Philadelphia, Grant, Research Grant, Developed |
The incidence of heart disease is on the rise, and new therapeutic strategies are needed. |
Released: 15-Sep-2017 5:05 AM EDT
Temple University |
MedicineChannels:Biotech, Blood Disorders, Bone Health, Cancer, Cell Biology, Chemistry, Children's Health, Complementary Medicine, Dermatology, Genetics, Healthcare, Immunology, Drug Resistance, Infectious Diseases, Kidney Disease, Men's Health, Mental Health, Military Health, Mindfulness, Neuro, Nursing, Nutrition, OBGYN, Oral Health, Pain, Personalized Medicine, Pharmaceuticals, |
Checking Your Neck, Colon Cancer Screening, New Microfluidic Device, and More in the Cancer News SourceClick here to go directly to the Cancer News Source |
Released: 11-Sep-2017 3:25 PM EDT
Newswise |
MedicineChannels:Cancer, Clinical Trial, clinical trial enrollment, clinical trial for cancer, Immunotherapy Clinical Trials, Immunotherapy, Stem Cells, stem cell clinical trials , Sarcoma, Blood Stem Cells, Cancer Treatment, Cirm |
Scientists at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have initiated a phase 1 clinical trial to test a novel cancer treatment for certain kinds of cancers that have a specific tumor marker called NY-ESO-1. |
Released: 11-Sep-2017 3:05 PM EDT
University of California, Los Angeles (UCLA), Health Sciences |
MedicineScienceChannels:San Diego, Palm Beach Florida, Antibodies, Stem Cells, induced pluripotent stem (iPS) cells, The Scripps Research Institute |
Scientists at The Scripps Research Institute (TSRI) have found a new approach to the “reprogramming” of ordinary adult cells into stem cells. |
Embargo expired: 11-Sep-2017 11:05 AM EDT
Released: 11-Sep-2017 11:05 AM EDT
Scripps Research Institute |
MedicineChannels:All Journal News, Alzheimer's and Dementia, Cell Biology, Dermatology, Mental Health, Neuro, Stem Cells, Cell (journal) Motor Neurons, Neurodegenative Disease, Developmental Biology |
In new research, scientists at Washington University School of Medicine in St. Louis have converted skin cells from healthy adults directly into motor neurons without going through a stem cell state. The technique makes it possible to study motor neurons of the human central nervous system in the lab. Unlike commonly studied mouse motor neurons, human motor neurons growing in the lab would be a new tool since researchers can’t take samples of these neurons from living people but can easily take skin samples. |
Embargo expired: 7-Sep-2017 12:00 PM EDT
Released: 5-Sep-2017 11:05 PM EDT
Washington University in St. Louis |
MedicineChannels:Penn Medicine, Telomeres, Perelman School of Medicine at the University of Pennsylvania, Muscular Dystrophy Research |
Researchers from the Perelman School of Medicine at the University of Pennsylvania have made a discovery about muscular dystrophy disorders that suggest new possibilities for treatment. In a study published today online in Stem Cell Reports, researchers found that stem cells in the muscles of muscular dystrophy patients may, at an early age, lose their ability to regenerate new muscle, due to shortened telomeres |
Embargo expired: 7-Sep-2017 12:00 PM EDT
Released: 6-Sep-2017 12:00 PM EDT
Perelman School of Medicine at the University of Pennsylvania |
MedicineScienceChannels:Grant Funded News, All Journal News, Bone Health, Cell Biology, Stem Cells, Transplantation, Journal of Experimental Medicine, Local - New York, Local - New York Metro Stem Cells, Bone Marrow, Stem Cell Transplantation |
Researchers in Germany have demonstrated that hematopoietic stem cell (HSC) transplants can be improved by treatments that temporarily prevent the stem cells from dying. The approach, which is described in a paper to be published September 7 in The Journal of Experimental Medicine, could allow those in need of such transplants, including leukemia and lymphoma patients, to be treated with fewer donor stem cells while limiting potential adverse side effects. |
Embargo expired: 7-Sep-2017 9:00 AM EDT
Released: 30-Aug-2017 11:00 AM EDT
The Rockefeller University Press |